MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD9 Codes        Equipment        Hospitals        Drugs        More..
  

Useful Websites

Global Translations
Medical and Clinical Translation

specialistinfo.com
Details of over 40,000 UK Specialists and over 42,000 GPs

Global RPH
medical software

Doctors Lounge
Ask a Doctor and Disease Information

Health News
from Medical News Today.

MRCP 1 Revision
123 Doc medical courses for junior doctors.

CoreyNahman
pharmaceutical news daily

Hospital Search
Worldwide hospital database, search by country or keyword.

Metric Conversions
The Converter Site - unit conversion tool.
home > drug information > Prilosec

Prilosec (omeprazole)


Company: Astra Merck
Approval Status: Approved December 1996
Treatment for: symptoms associated with gastroesophageal reflux disease (GERD)
Areas: Gastroenterology
Possible similar drugs: Prilosec; Prilosec; Prilosec

| General Information | Side Effects | Additional Information |


General Information

Other Useful Resources

Prilosec has been approved for the treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD). The recommended adult dose is 20 mg daily for up to four weeks in patients with symptomatic GERD.

In addition to its new indication, Prilosec is also indicated for use in combination with the antibiotic Biaxin for the eradication of H. pylori infection associated with duodenal ulcers to reduce the risk of recurrence. H. Pylori is the bacterium now believed to cause approximately 90% of peptic ulcers. Prilosec is also indicated as first-line therapy for erosive esophagitis, for the maintenance of healed erosive esophagitis, for short-term treatment of active duodenal ulcer, and active benign gastric ulcer. It is also indicated for the treatment of certain pathological hypersecretory conditions.



< back to top

Side Effects

Prilosec is generally well tolerated; side effects, which are usually transient and mild, include headache, diarrhea, abdominal pain and nausea.



< back to top

Additional Information

Although many people experience heartburn from time to time, patients who get heartburn more than two to three times a week may have a more serious condition called GERD, an acid-related disorder affecting approximately 19 million Americans. GERD results when the lower esophageal sphincter, the muscle between the stomach and the esophagus, or food tube, relaxes allowing harsh stomach acid to splash back into the esophagus. GERD is a potentially serious medical condition, which can lead to significant complications, including ulcers, narrowing of the esophagus, and precancerous changes within the lining of the esophagus.

Because heartburn is the most common symptom of GERD, the disease is often misunderstood and underestimated by patients and doctors. Prilosec significantly reduces acid directly at the final site of acid production, the acid pumps in the cells of the stomach.



< back to top



The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.




free web search box


pda medical dictionary
pda software - $15

PDA Medical Dictionary

only $15

Take MediLexicon's abbreviations search with you where-ever you go with our PDA software. As an extra, this software is available with an extra medical dictionary...

>> Click here for more on the PDA Medical Dictionary <<




add to google

Add our searches to your Google homepage.

Add to Google

The 60 seconds challenge: Add these searches to your Google homepage within 60 seconds - simply click here and follow these instructions


Receive the latest medical news on your Google homepage.

Add to Google

The 60 seconds challenge: Receive the latest medical news on your Google homepage within 60 seconds - simply click here and follow these instructions





Privacy Policy   |    Disclaimer      

MediLexicon International Ltd, UK Office: +44 (0) 1625 415 347
MediLexicon International Ltd © 2009 All rights reserved.